Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Thalassemia × Thiotepa × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Classical hematology 1

Conditions

Thalassemia 1 Immunologic Deficiency Syndromes 1 Hemoglobinopathies 1 Hematologic Neoplasms 1 Fanconi Anemia 1 Anemia, Sickle Cell 1

Interventions

fludarabine 2 fludarabine phosphate 1 Thiotepa 1 Melphalan 1 Erythrocyte Count 1 Clofarabine 1 Blood Transfusion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03609840 2023-09-21

Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

University of California, San Francisco

Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡